Skip to main content
. 2024 Aug 28;16(17):2877. doi: 10.3390/nu16172877

Table 2.

Participants’ characteristics among the dietary patterns.

Rice Group Vegetables Group Seafoods Group Sweets Group Rice vs. Vegetables Rice vs. Seafoods Rice vs. Sweets
n = 259 n = 160 n = 151 n = 157
age (year) 52 (39–65) 45 (36–58) 61 (42–70) 55 (39–64) 0.011 0.003 0.981
sex, male 115 (44.4%) 28 (17.5%) 67 (44.4%) 39 (24.8%) <0.001
BMI (kg/m2) 22.7 (20.5–24.7) 21.5 (19.4–24.1) 22.8 (20.7–25.6) 21.8 (19.3–24.5) 0.007 .0.406 0.018
CAP (dB/m) 222.0 (192.0–261.0) 208.0 (163.8–253.8) 235.0 (192.0–275.0) 213.0 (174.5–262.5) 0.050 0.343 0.477
LSM (kPa) 4.4 (3.4–5.4) 4.2 (3.5–4.9) 4.3 (3.5–5.2) 4.4 (3.6–5.6) 0.849 0.996 0.802
AST (IU/L) 21.0 (17.0–25.0) 19.0 (16.0–22.0) 21.0 (18.0–26.0) 19.0 (16.5–24.0) <0.001 0.607 0.141
ALT (IU/L) 19.0 (14.0–26.0) 15.0 (12.0–19.8) 19.0 (15.0–25.0) 16.0 (12.0–23.0) <0.001 0.734 0.058
γGT (IU/L) 21.0 (15.0–32.0) 18.0 (14.0–25.8) 23.0 (17.0–35.0) 18.0 (14.0–30.0) 0.013 0.109 0.232
FPG (mg/dL) 91.0 (86.0–98.0) 88.0 (84.0–93.0) 94.0 (87.0–103.0) 91.0 (85.0–99.5) 0.009 0.003 0.999
HbA1c (%) 5.7 (5.5–5.9) 5.6 (5.4–5.8) 5.7 (5.5–6.0) 5.7 (5.5–5.9) 0.001 0.396 0.954
HOMA-IR 1.1 (0.8–1.6) 1.1 (0.8–1.5) 1.3 (1.0–1.9) 1.2 (0.9–1.6) 0.725 0.004 0.554
TG (mg/dL) 82.0 (54.0–118.0) 62.0 (47.3–84.0) 89.0 (63.0–118.0) 72.0 (53.0–104.0) <0.001 0.305 0.349
HDL (mg/dL) 60.0 (49.0–71.0) 69.0 (59.0–82.0) 62.0 (52.0–75.0) 64.0 (54.5–77.5) <0.001 0.273 0.02
LDL (mg/dL) 118.0 (99.0–139.0) 110.5 (92.3–129.0) 119.0 (107.0–142.0) 116.0 (95.5–138.0) 0.053 0.627 0.994
smoking habit (%) 34 (13.1%) 14 (8.8%) 29 (19.2%) 16 (10.2%) 0.031
exercise habit (%) 30 (11.6%) 38 (23.8%) 37 (24.5%) 22 (14.0%) <0.001
MASLD (%) 78 (30.1%) 44 (27.5%) 57 (37.7%) 41 (26.1%) 0.118

Data are presented as numbers (%) or median (range). BMI, body mass index; CAP, controlled attenuation parameter; LSM, liver stiffness measure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γGT, γ-glutamyl transpeptidase, FPG, fasting plasma glucose; TG, triglyceride; HbA1c, hemoglobin A1c; HOMA-IR, homeostasis model assessment-insulin resistance; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; MASLD, metabolic dysfunction-associated steatotic liver disease.